B-cell adult acute lymphocytic leukemia
MONDO:0000814An acute B-lymphoblastic leukemia occurring in adults.
Also known as: B acute lymphoblastic leukaemia, B acute lymphoblastic leukemia, B cell adult ALL, B cell adult acute lymphoblastic leukaemia, B cell adult acute lymphoblastic leukemia, B cell adult acute lymphocytic leukaemia, B cell adult acute lymphocytic leukemia, B-cell adult ALL
2026 clinical trials for this condition and its sub-types, 12 tagged with B-cell adult acute lymphocytic leukemia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New drug combo shows promise for tough leukemia cases
Disease control CompletedThis phase 2 trial tested a combination of two drugs, ibrutinib and blinatumomab, in 19 adults with B-cell acute lymphoblastic leukemia that had come back or wasn't responding to treatment. The goal was to see how many patients achieved complete remission. The study is completed,…
Phase 2 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Experimental drug pair targets tough leukemias
Disease control CompletedThis early-phase trial tested a combination of two drugs—veliparib and temozolomide—in 66 adults with relapsed or refractory acute leukemias. Veliparib blocks a DNA repair enzyme, while temozolomide damages cancer cell DNA. The goal was to find the safest dose and check for side …
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New combo therapy shows promise for relapsed leukemia
Disease control CompletedThis early-phase trial tested a combination of two drugs—blinatumomab and pembrolizumab—in 16 adults with relapsed or refractory B-cell acute lymphoblastic leukemia (B-ALL) who had high levels of cancer cells in their bone marrow. The goal was to see if adding pembrolizumab to bl…
Phase 1/2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC